A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus

QJM: An International Journal of Medicine

Volumn 101, Issue 5, 2008, Pages 351-358

  Smith, Damian Martin ^a,b   Pickering, R M ^a   Lewith, G T ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; PLACEBO; VANADYL SULFATE;

BIBLIOGRAPHIC DATABASE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA EXTRACTION; DIABETES CONTROL; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG WITHDRAWAL; GASTROINTESTINAL TOXICITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 42949154676     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn003     Document Type: Review

References (24)

1. UKPDS, United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-53.
2. Diabetes e-Atlas. International Diabetes Federation, 2007. Online at http://www.eatlas.idf.org/ (20/11/2007, date last accessed).
3. O'Connell BS. Selected vitamins and minerals in the management of diabetes. Diabetes Spectrum 2001; 14:33-48.
4. Kligler B, Lynch D. An integrative approach to the management of type 2 diabetes mellitus. Altern Ther Health Med 2003; 9:24-32.
5. Singh RB, Niaz MA, Rastogi SS, Bajaj S, Gaoli Z, Shoumin Z. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 1998; 17:564-70.
6. Anderson RA. Role of dietary factors: Micronutrients. Nutr Rev 2000; 58:S10-S11.
7. Cunningham JJ. Micronutrients as nutritional interventions in diabetes mellitus. J Am College Nutr 1998; 17:7-10.
8. Werbach MR, Moss J. Textbook of Nutritional Medicine. Third Lane Press, Tarzana, CA, 1999.
9. Kumar P, Clark M. Clinical Medicine, 5th edn. W.B Saunders Co Ltd, Edinbrugh, 2002.
10. Longmore M, Wilkinson IB, Rajagopalan S. Oxford Handbook of Clinical Medicine, 6th edn. Oxford University Press, Oxford, 2004.
11. American Diabetes Association. Dietary Advice. Online at http://www.diabetes.org/nutrition-and-recipies (2/11/2006, date last accessed).
12. Verma S, Cam MC, McNeill JH. Nutritional factors that can favorably influence the glucose/insulin system: Vanadium. J Am Coll Nutr. 1998; 17:11-18.
13. Pandey SK, Anand-Srivastava MB, Srivastava AK. Vanadyl sulfate-stimulated glycogen synthesis is associated with activation of phosphatidylinositol 3-kinase and is independent of insulin receptor tyrosine phosphorylation. Biochemistry 1998; 37:7006-14.
14. MECRG. The Cochrane Library. Information on the Metabolic and Endocrine Disorders Group. Definition of Diabetes Mellitus, 2003. Online at http://www.cc-endoc.info (6/10/2006, date last accessed).
15. Centralised Information Service for Complementary Medicine. Online at http://www.rccm.org.uk/ciscom/CISCOM_intro.asp (2/10/2004, date last accessed).
16. NCC. Nordic Cochrane Center. Review Manager. Software Download and documentation available at: http://www.cc-ims.net/RevMan (22/3/2006, date last accessed).
17. MECRG. The Cochrane Library. Information on the Metabolic and Endocrine Disorders Group. Definition of Diabetes Mellitus, 2003. Online at http://www.cc-endoc.info/docs/datacapture (17/4/2005, date last accessed).
18. Egger M, Davey-Smith G, Altman D. edn. Systematic Reviews in Healthcare; Meta-Analysis in Context, 2nd edn. London, BMJ Publishing Group, 2001.
19. MECRG. The Cochrane Library. Information on the Metabolic and Endocrine Disorders Group. Definition of Diabetes Mellitus, 2003. Online at http://www.cc-endoc.info/processes/qualityassessment (10/5/ 2005, date last accessed).
20. Cusi K, Cukier S, DeFronzo RA, Torres M, Puchulu FM, Redondo JC. Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes. J Clin Endocrinol Metabol 2001; 86:1410-17.
21. Halberstam M, Cohen N, Shlimovich P; Rossetti L, Shamoon H. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. [erratum appears in Diabetes 1996 Sep;45(9):V285] Diabetes 1996; 45:659-66.
22. Goldfine AB, Patti ME, Zuberi L, Goldstein BJ, LeBlanc R, Landaker E, et al. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: In vivo and in vitro studies. Metabolism: Clin Exp 2000; 49:400-10.
23. Boden G, Chen X, Ruiz J, van Rossum GD, Turco S. Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with: non-insulin-dependent diabetes mellitus. Metabolism: Clin Exp 1996; 45:1130-35.
24. Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rossetti L. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1995; 95:2501-09.